Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2010 1
2011 1
2012 6
2014 5
2015 6
2016 5
2017 10
2018 8
2019 16
2020 22
2021 19
2022 11
2023 17
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.
Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, Bellmann-Weiler R, Adolf C, Wolf D, Pirklbauer M, Graziadei I, Gänzer H, von Bary C, May AE, Wöll E, von Scheidt W, Rassaf T, Duerschmied D, Brenner C, Kääb S, Metzler B, Joannidis M, Kain HU, Kaiser N, Schwinger R, Witzenbichler B, Alber H, Straube F, Hartmann N, Achenbach S, von Bergwelt-Baildon M, von Stülpnagel L, Schoenherr S, Forer L, Embacher-Aichhorn S, Mansmann U, Rizas KD, Massberg S; ACEI-COVID investigators. Bauer A, et al. Lancet Respir Med. 2021 Aug;9(8):863-872. doi: 10.1016/S2213-2600(21)00214-9. Epub 2021 Jun 11. Lancet Respir Med. 2021. PMID: 34126053 Free PMC article. Clinical Trial.
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy.
Michel L, Helfrich I, Hendgen-Cotta UB, Mincu RI, Korste S, Mrotzek SM, Spomer A, Odersky A, Rischpler C, Herrmann K, Umutlu L, Coman C, Ahrends R, Sickmann A, Löffek S, Livingstone E, Ugurel S, Zimmer L, Gunzer M, Schadendorf D, Totzeck M, Rassaf T. Michel L, et al. Among authors: totzeck m. Eur Heart J. 2022 Jan 31;43(4):316-329. doi: 10.1093/eurheartj/ehab430. Eur Heart J. 2022. PMID: 34389849
Modern concepts in cardio-oncology.
Rassaf T, Totzeck M. Rassaf T, et al. Among authors: totzeck m. J Thorac Dis. 2018 Dec;10(Suppl 35):S4386-S4390. doi: 10.21037/jtd.2018.11.110. J Thorac Dis. 2018. PMID: 30701105 Free PMC article. Review.
Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer.
Lena A, Wilkenshoff U, Hadzibegovic S, Porthun J, Rösnick L, Fröhlich AK, Zeller T, Karakas M, Keller U, Ahn J, Bullinger L, Riess H, Rosen SD, Lyon AR, Lüscher TF, Totzeck M, Rassaf T, Burkhoff D, Mehra MR, Bax JJ, Butler J, Edelmann F, Haverkamp W, Anker SD, Packer M, Coats AJS, von Haehling S, Landmesser U, Anker MS. Lena A, et al. Among authors: totzeck m. J Am Coll Cardiol. 2023 Apr 25;81(16):1569-1586. doi: 10.1016/j.jacc.2023.02.039. J Am Coll Cardiol. 2023. PMID: 37076211 Free article.
Cardiovascular Damage Associated With Chest Irradiation.
Mrotzek SM, Rassaf T, Totzeck M. Mrotzek SM, et al. Among authors: totzeck m. Front Cardiovasc Med. 2020 Mar 20;7:41. doi: 10.3389/fcvm.2020.00041. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 32266294 Free PMC article. Review.
Cardiotoxicity from immune checkpoint inhibitors.
Michel L, Rassaf T, Totzeck M. Michel L, et al. Among authors: totzeck m. Int J Cardiol Heart Vasc. 2019 Sep 7;25:100420. doi: 10.1016/j.ijcha.2019.100420. eCollection 2019 Dec. Int J Cardiol Heart Vasc. 2019. PMID: 31517036 Free PMC article. Review.
Nitrite-Nitric Oxide Signaling and Cardioprotection.
Totzeck M, Hendgen-Cotta UB, Rassaf T. Totzeck M, et al. Adv Exp Med Biol. 2017;982:335-346. doi: 10.1007/978-3-319-55330-6_18. Adv Exp Med Biol. 2017. PMID: 28551796 Review.
Proteomics: A Tool to Study Platelet Function.
Shevchuk O, Begonja AJ, Gambaryan S, Totzeck M, Rassaf T, Huber TB, Greinacher A, Renne T, Sickmann A. Shevchuk O, et al. Among authors: totzeck m. Int J Mol Sci. 2021 Apr 30;22(9):4776. doi: 10.3390/ijms22094776. Int J Mol Sci. 2021. PMID: 33946341 Free PMC article. Review.
CAR T-cell cancer therapies: do not forget the heart.
Totzeck M, Anker MS, Rassaf T. Totzeck M, et al. Eur Heart J. 2023 Jun 9;44(22):2043-2045. doi: 10.1093/eurheartj/ehad175. Eur Heart J. 2023. PMID: 36994886 No abstract available.
Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart.
Korste S, Settelmeier S, Michel L, Odersky A, Stock P, Reyes F, Haj-Yehia E, Anker MS, Grüneboom A, Hendgen-Cotta UB, Rassaf T, Totzeck M. Korste S, et al. Among authors: totzeck m. Int J Mol Sci. 2023 Mar 23;24(7):6052. doi: 10.3390/ijms24076052. Int J Mol Sci. 2023. PMID: 37047026 Free PMC article.
114 results